Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04205708 · ClinicalTrials.gov registry record
Screening Strategy for Early Diagnosis of Silicosis in At-Risk Populations in Oklahoma
A clinical trial of Silicosis and Pneumoconiosis; Silica, sponsored by University of Oklahoma.
- Completed
- Registry status
- 183
- Enrollment target
- 1
- Study location
NCT04205708 is a study of Silicosis and Pneumoconiosis; Silica that has completed, run by University of Oklahoma. The registered enrollment target is 183 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04205708, a study of Silicosis and Pneumoconiosis; Silica, has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- 183 participants
- Enrollment target
- 1
- Study location
Study Summary
Silicosis, a preventable yet irreversible occupational lung disease, has an insidious onset with a latency period for diagnosis extending beyond 10 years from the initial exposure. The central hypothesis of this study is that silicosis cases may currently be going undetected. The long-term goal of this research is to determine the current prevalence and forecast the future prevalence of silicosis and other pneumoconiosis among working populations in Oklahoma and to assist the public health and the healthcare system in planning for a potential resurgence of silicosis.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Pulmonary Function Test
- DIAGNOSTIC_TEST Tuberculosis test
- DIAGNOSTIC_TEST Chest X-ray
Study Locations (1)
Oklahoma
- University of Oklahoma Health Sciences Center - Oklahoma City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 183 participants |
| Start Date | 2019-01-14 |
| Est. Completion | 2022-06-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04205708
The ClinicalTrials.gov registry entry for NCT04205708 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 183 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Silicosis appearing as the primary indexed condition, and to 3 interventions - of which Pulmonary Function Test is the first listed.
NCT04205708 reports 1 study location spanning 1 distinct geographic area - top geographies include Oklahoma.
Frequently Asked Questions
What is clinical trial NCT04205708 about?
NCT04205708 is a clinical study titled "Screening Strategy for Early Diagnosis of Silicosis in At-Risk Populations in Oklahoma". Silicosis, a preventable yet irreversible occupational lung disease, has an insidious onset with a latency period for diagnosis extending beyond 10 years from the initial exposure. The central hypothesis of this study is that silicosis cases may currently be going undetected. The long-term goal of t...
What is the current status of trial NCT04205708?
This trial is currently completed. The enrollment target is 183 participants. The study started on 2019-01-14. Estimated completion is 2022-06-10.
What conditions does trial NCT04205708 study?
This clinical trial studies the following conditions: Silicosis, Pneumoconiosis; Silica.
What interventions are being tested in trial NCT04205708?
The interventions under investigation include: Pulmonary Function Test (DIAGNOSTIC_TEST), Tuberculosis test (DIAGNOSTIC_TEST), Chest X-ray (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04205708?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04205708 being conducted?
This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.